Loading clinical trials...
Loading clinical trials...
To evaluate the potential usefulness of 18F-S16/T807 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patien...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tianjin Medical University
Collaborators
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT04838301 · Alzheimer Dementia, Late Onset Alzheimer Disease, and more
NCT06932809 · Tauopathies
NCT06032026 · Tauopathies
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions